These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11585718)

  • 41. The extension mechanism of epithelia: a new concept.
    Tucker R
    Res Vet Sci; 1968 Sep; 9(5):397-9. PubMed ID: 5684091
    [No Abstract]   [Full Text] [Related]  

  • 42. Adenocarcinoma of the gallbladder.
    CAMERON ; SCRATCH
    Treat Serv Bull; 1950 Jan; 5(1):14-7. PubMed ID: 15406153
    [No Abstract]   [Full Text] [Related]  

  • 43. Multiple Biliary Adenofibromas with Adenocarcinoma of Gallbladder: Histopathological Conundrum.
    Ahuja N; Mitra S; Bal A; Das A; Tandup C; Krishnaraju VS
    J Gastrointest Cancer; 2023 Sep; 54(3):986-988. PubMed ID: 36048315
    [No Abstract]   [Full Text] [Related]  

  • 44. [Epithelium of the human gallbladder].
    FERNER H
    Z Zellforsch Mikrosk Anat; 1949; 34(5):503-13. PubMed ID: 15391258
    [No Abstract]   [Full Text] [Related]  

  • 45. Adenocarcinoma of the gallbladder.
    Carty NJ; Johnson CD
    J R Soc Med; 1991 Jun; 84(6):382. PubMed ID: 20894808
    [No Abstract]   [Full Text] [Related]  

  • 46. Identification of genes associated with gall bladder cell carcinogenesis: Implications in targeted therapy of gall bladder cancer.
    Ghosh I; Dey Ghosh R; Mukhopadhyay S
    World J Gastrointest Oncol; 2023 Dec; 15(12):2053-2063. PubMed ID: 38173427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New and Old Key Players in Liver Cancer.
    Cuesta ÁM; Palao N; Bragado P; Gutierrez-Uzquiza A; Herrera B; Sánchez A; Porras A
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138981
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Novel Mouse Model of Intrahepatic Cholangiocarcinoma Induced by Azoxymethane.
    Shirakami Y; Kato J; Ohnishi M; Taguchi D; Maeda T; Ideta T; Kubota M; Sakai H; Tomita H; Tanaka T; Shimizu M
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gallbladder cancer: current and future treatment options.
    Zhou Y; Yuan K; Yang Y; Ji Z; Zhou D; Ouyang J; Wang Z; Wang F; Liu C; Li Q; Zhang Q; Li Q; Shan X; Zhou J
    Front Pharmacol; 2023; 14():1183619. PubMed ID: 37251319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gallbladder Cancer: Current Multimodality Treatment Concepts and Future Directions.
    Sturm N; Schuhbaur JS; Hüttner F; Perkhofer L; Ettrich TJ
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selecting an Appropriate Experimental Animal Model for Cholangiocarcinoma Research.
    Li M; Zhou X; Wang W; Ji B; Shao Y; Du Q; Yao J; Yang Y
    J Clin Transl Hepatol; 2022 Aug; 10(4):700-710. PubMed ID: 36062286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overcome Drug Resistance in Cholangiocarcinoma: New Insight Into Mechanisms and Refining the Preclinical Experiment Models.
    Zheng Q; Zhang B; Li C; Zhang X
    Front Oncol; 2022; 12():850732. PubMed ID: 35372014
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HER2 Aberrations as a Novel Marker in Advanced Biliary Tract Cancer.
    Kim H; Kim R; Kim HR; Jo H; Kim H; Ha SY; Park JO; Park YS; Kim ST
    Front Oncol; 2022; 12():834104. PubMed ID: 35252005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Environmental and Lifestyle Risk Factors in the Carcinogenesis of Gallbladder Cancer.
    Pérez-Moreno P; Riquelme I; García P; Brebi P; Roa JC
    J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Severe liver disease resembling PSC in mice with K5-Cre mediated deletion of Krüppel-like factor 5 (Klf5).
    Bergström Å; Gerling M; Van Hul N; Fernández Moro C; Rozell B; Toftgård R; Sur I
    Transgenic Res; 2021 Oct; 30(5):701-707. PubMed ID: 34117597
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent Advances in Implantation-Based Genetic Modeling of Biliary Carcinogenesis in Mice.
    Izumiya M; Kato S; Hippo Y
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34064809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Precision modeling of gall bladder cancer patients in mice based on orthotopic implantation of organoid-derived tumor buds.
    Kato S; Fushimi K; Yabuki Y; Maru Y; Hasegawa S; Matsuura T; Kurotaki D; Suzuki A; Kobayashi N; Yoneda M; Higurashi T; Enaka M; Tamura T; Hippo Y; Nakajima A
    Oncogenesis; 2021 Apr; 10(4):33. PubMed ID: 33866327
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Novel
    De Paolis E; Urbani A; Salvatore L; Foca L; Tortora G; Minucci A; Concolino P
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33671809
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell of origin in biliary tract cancers and clinical implications.
    Moeini A; Haber PK; Sia D
    JHEP Rep; 2021 Apr; 3(2):100226. PubMed ID: 33665585
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the chemopreventive potentials of ezetimibe and aspirin in a novel mouse model of gallbladder preneoplasia.
    Rosa L; Lobos-González L; Muñoz-Durango N; García P; Bizama C; Gómez N; González X; Wichmann IA; Saavedra N; Guevara F; Villegas J; Arrese M; Ferreccio C; Kalergis AM; Miquel JF; Espinoza JA; Roa JC
    Mol Oncol; 2020 Nov; 14(11):2834-2852. PubMed ID: 33326125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.